ROSEN, THE TOP RANKED GLOBAL ADVISOR, ENCOURAGES THE INVESTORS OF CARIBU BIOSCIENCES, INC. to secure the Board before an important deadline in the Securities Class Action

New York, New York — (Newsfile Corp. – January 11, 2025) – FOR WHAT: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”). If you want to serve as the main plaintiff, you must move the Court no later than February 24, 2025.

SO WHAT: If you purchased Caribou securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee agreement.

WHAT TO DO NEXT: To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you want to serve as the main plaintiff, you must move the Court no later than February 24, 2025. A principal plaintiff is a representative party who acts on behalf of the other members of the class in conducting the litigation.

WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies issuing notices do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually litigate securities class actions, but are simply intermediaries who refer clients or partners with law firms that actually litigate cases. Be cautious in selecting counsel. The Rosen Law Firm represents investors around the globe, focusing its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm has obtained the largest securities class action settlement against a Chinese Company at the time. Rosen Law Firm was ranked #1 by ISS Securities Class Action (WA:) Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured more than $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, throughout the Class Period, the defendants made false and misleading statements and/or failed to disclose that: (1) the defendants overestimated the safety, efficacy and durability of CB-010 regarding autologous CAR-T cell therapies approved in the treatment of patients. with r/r B-NHL and/or LBCL, as well as CB-010’s overall clinical results and commercial prospects; (2) Caribou was at significant risk of having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities associated with the CAR-NK allogeneic platform; (3) the foregoing was likely to have a material adverse impact on Caribou’s business and operations; and (4) as a result, the defendants’ public statements were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims that investors suffered damages.

To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988, call Phillip Kim, Esq. toll-free at 866-767-3653, or email case@rosenlegal.com for information about the class action.

No Class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the advice of your choice. You can also be an absent class member and do nothing at this point. The investor’s ability to share in any potential future recovery is not dependent on serving as the lead actor.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https :/ /www.facebook.com/rosenlawfirm/.

Attorney Advertising. Previous results do not guarantee a similar result.

——————————–

To view the source version of this press release, visit https://www.newsfilecorp.com/release/236822